Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint

por Chenard, Stephen, Jackson, Chelsea, Vidotto, Thiago, Chen, Lina, Hardy, Céline, Jamaspishvilli, Tamara, Berman, David, Siemens, D. Robert, Koti, Madhuri
Publicado 2021

Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers

por Hardy, Céline S.C., Ghaedi, Hamid, Slotman, Ava, Sjödahl, Gottfrid, Gooding, Robert J., Berman, David M., Jackson, Chelsea L.
Publicado 2022

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy

por Hesswani, Charles, Jackson, Chelsea L., Marcq, Gautier, Hardy, Céline, Kool, Ronald, Mansure, Jose Joao, Brimo, Fadi, Berman, David M., Kassouf, Wassim
Publicado 2023

Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer

por Jackson, Chelsea L, Chen, Lina, Hardy, Céline SC, Ren, Kevin YM, Visram, Kash, Bratti, Vanessa F, Johnstone, Jeannette, Sjödahl, Gottfrid, Siemens, David Robert, Gooding, Robert J, Berman, David M
Publicado 2021